The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

M.S. Gromova

Gamaleya National Research Center of Epidemiology and Microbiology

A.V. Gromov

Gamaleya National Research Center of Epidemiology and Microbiology

T.M. Grunina

Gamaleya National Research Center of Epidemiology and Microbiology;
All-Russia Research Institute of Agricultural Biotechnology

A.M. Lyashchuk

Gamaleya National Research Center of Epidemiology and Microbiology

Z.M. Galushkina

Gamaleya National Research Center of Epidemiology and Microbiology

M.E. Subbotina

Gamaleya National Research Center of Epidemiology and Microbiology;
All-Russia Research Institute of Agricultural Biotechnology

I.B. Esmagambetov

Gamaleya National Research Center of Epidemiology and Microbiology

E.I. Ryabova

Gamaleya National Research Center of Epidemiology and Microbiology

V.V. Prokofiev

Gamaleya National Research Center of Epidemiology and Microbiology

A.V. Kovyrshina

Gamaleya National Research Center of Epidemiology and Microbiology

A.A. Ilyukhina

Gamaleya National Research Center of Epidemiology and Microbiology

A.Y. Shelkov

Gamaleya National Research Center of Epidemiology and Microbiology

A.S. Karyagina

Gamaleya National Research Center of Epidemiology and Microbiology;
All-Russia Research Institute of Agricultural Biotechnology;
Belozersky Institute of Physico-Chemical Biology — Lomonosov Moscow State University

V.G. Lunin

Gamaleya National Research Center of Epidemiology and Microbiology;
All-Russia Research Institute of Agricultural Biotechnology

Recombinant RBD of SARS-CoV-2 spike protein: production in Escherichia coli cells, binding to antibodies and antiviral activity

Authors:

M.S. Gromova, A.V. Gromov, T.M. Grunina, A.M. Lyashchuk, Z.M. Galushkina, M.E. Subbotina, I.B. Esmagambetov, E.I. Ryabova, V.V. Prokofiev, A.V. Kovyrshina, A.A. Ilyukhina, A.Y. Shelkov, A.S. Karyagina, V.G. Lunin

More about the authors

Views: 551

Downloaded: 2

To cite this article:

Gromova MS, Gromov AV, Grunina TM, Lyashchuk AM, Galushkina ZM, Subbotina ME, Esmagambetov IB, Ryabova EI, Prokofiev VV, Kovyrshina AV, Ilyukhina AA, Shelkov AY, Karyagina AS, Lunin VG. Recombinant RBD of SARS-CoV-2 spike protein: production in Escherichia coli cells, binding to antibodies and antiviral activity. Molecular Genetics, Microbiology and Virology. 2023;41(2):28‑35. (In Russ.)
https://doi.org/10.17116/molgen20234102128

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.